239 related articles for article (PubMed ID: 28473257)
1. Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson's disease.
Hao Y; Shabanpoor A; Metz GA
Neurosci Lett; 2017 Jun; 651():79-87. PubMed ID: 28473257
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid receptor expression and sub-cellular localization in dopamine neurons of the rat midbrain.
Hensleigh E; Pritchard LM
Neurosci Lett; 2013 Nov; 556():191-5. PubMed ID: 24121048
[TBL] [Abstract][Full Text] [Related]
3. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
[TBL] [Abstract][Full Text] [Related]
4. Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy.
Liang XB; Liu XY; Li FQ; Luo Y; Lu J; Zhang WM; Wang XM; Han JS
Brain Res Mol Brain Res; 2002 Dec; 108(1-2):51-9. PubMed ID: 12480178
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats.
Dickerson JW; Hemmerle AM; Numan S; Lundgren KH; Seroogy KB
Neuroscience; 2009 Sep; 163(1):482-9. PubMed ID: 19505538
[TBL] [Abstract][Full Text] [Related]
6. Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease.
Smith LK; Jadavji NM; Colwell KL; Katrina Perehudoff S; Metz GA
Eur J Neurosci; 2008 Apr; 27(8):2133-46. PubMed ID: 18412632
[TBL] [Abstract][Full Text] [Related]
7. Loss of dopaminergic neurons occurs in the ventral tegmental area and hypothalamus of rats following chronic stress: Possible pathogenetic loci for depression involved in Parkinson's disease.
Sugama S; Kakinuma Y
Neurosci Res; 2016 Oct; 111():48-55. PubMed ID: 27142317
[TBL] [Abstract][Full Text] [Related]
8. Search for the presence of glucocorticoid receptors in dopaminergic neurons of rat ventral tegmental area and substantia nigra.
Czyrak A; Chocyk A
Pol J Pharmacol; 2001; 53(6):681-4. PubMed ID: 11985346
[TBL] [Abstract][Full Text] [Related]
9. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
[TBL] [Abstract][Full Text] [Related]
10. ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia.
Galter D; Buervenich S; Carmine A; Anvret M; Olson L
Neurobiol Dis; 2003 Dec; 14(3):637-47. PubMed ID: 14678778
[TBL] [Abstract][Full Text] [Related]
11. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
Ogura T; Ogata M; Akita H; Jitsuki S; Akiba L; Noda K; Hoka S; Saji M
Neurosci Res; 2005 Mar; 51(3):299-308. PubMed ID: 15710494
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of RET and GDNF family receptor, GFR-α1, between striatum and substantia nigra following nigrostriatal lesion: A case for diminished GDNF-signaling.
Kasanga EA; Han Y; Navarrete W; McManus R; Shifflet MK; Parry C; Barahona A; Manfredsson FP; Nejtek VA; Richardson JR; Salvatore MF
Exp Neurol; 2023 Aug; 366():114435. PubMed ID: 37178997
[TBL] [Abstract][Full Text] [Related]
13. Environment- and activity-dependent dopamine neurotransmitter plasticity in the adult substantia nigra.
Aumann TD
J Chem Neuroanat; 2016 Apr; 73():21-32. PubMed ID: 26718607
[TBL] [Abstract][Full Text] [Related]
14. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
[TBL] [Abstract][Full Text] [Related]
15. 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis.
Burke WJ; Li SW; Williams EA; Nonneman R; Zahm DS
Brain Res; 2003 Nov; 989(2):205-13. PubMed ID: 14556942
[TBL] [Abstract][Full Text] [Related]
16. Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area.
Lessard A; Pickel VM
Neuroscience; 2005; 135(4):1309-23. PubMed ID: 16165296
[TBL] [Abstract][Full Text] [Related]
17. Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease.
Metz GA; Piecharka DM; Kleim JA; Whishaw IQ
Brain Res; 2004 Nov; 1026(1):126-35. PubMed ID: 15476704
[TBL] [Abstract][Full Text] [Related]
18. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
Maingay M; Romero-Ramos M; Carta M; Kirik D
Neurobiol Dis; 2006 Sep; 23(3):522-32. PubMed ID: 16806952
[TBL] [Abstract][Full Text] [Related]
19. Social defeat stress increases expression of mu-opioid receptor mRNA in rat ventral tegmental area.
Nikulina EM; Hammer RP; Miczek KA; Kream RM
Neuroreport; 1999 Sep; 10(14):3015-9. PubMed ID: 10549815
[TBL] [Abstract][Full Text] [Related]
20. Predominant surface distribution of neurokinin-3 receptors in non-dopaminergic dendrites in the rat substantia nigra and ventral tegmental area.
Lessard A; Grady EF; Bunnett NW; Pickel VM
Neuroscience; 2007 Feb; 144(4):1393-408. PubMed ID: 17197098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
